In short
- Twenty adults with social anxiety disorder had two MDMA-assisted therapy sessions as part of a clinical trial.
- They felt strong self-compassion during the sessions, and their everyday self-compassion rose clearly after the first session and again after the second.
- More self-compassion went together with less depression and, above all, less internalised shame and a stronger sense of belonging.
What the researchers did
This was a secondary analysis of the same small trial behind our earlier summary on belonging, gratitude and purpose. Researchers measured self-compassion during the dosing sessions and across the 16 weeks of treatment, and looked at how it related to outcomes such as social anxiety, shame and depression.
What they found
Self-compassion increased most after the first session and continued to rise after the second. Feeling self-compassion during the sessions predicted lower depression and internalised shame afterwards, beyond where people started. Growth in everyday self-compassion after the second session went with less shame and less feeling of not belonging.
Why it matters
Shame is often what keeps people small, quiet and alone. Being able to meet yourself with kindness, even for a few hours, can show what is possible. The work is then to make it a habit. Kindness towards oneself is something we return to again and again in preparation and integration, because it helps an insight last.
Keep in mind
This is a preprint with only 20 participants and no comparison of what self-compassion would do without MDMA. It concerns MDMA in a clinical setting, which may not apply to other substances or to retreats.
Making sense of an experience
Our psychologists and psychotherapists offer one-to-one integration sessions, online or in Edinburgh.
Integration therapyThis summary is for information only and is not medical advice. Psychedelics are controlled substances in many countries, including the UK.
You may also like
Shipibo Healing and Lasting Change: What a 12-Month Study Found
Following 264 Western guests of a Shipibo-led centre in Peru for a year, researchers found lasting gains in quality of life and changes in personality.
Dr Christoph Zwolan · 22 May 2026
ResearchWhen the Self Falls Quiet: Ego Dissolution and the Language of the Self
A brain-imaging study found that during strong ego dissolution on psilocybin, people’s language and meaning networks became more alike.
Dr Christoph Zwolan · 12 November 2026
ResearchBeyond the Substance: Why the Therapy Around Psychedelics Matters
A review of 44 clinical trials found nearly all used preparation, dosing and integration, but the psychological support around them varied enormously.
Monika Knitter · 13 October 2026
